As reported by the American Journal of Managed Care, the approval of an oral semaglutide formulation marked the beginning of what many are calling the oral GLP-1 era. In December 2025, the FDA approved the Wegovy (semaglutide) tablet as the first once-daily oral GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight
Sagging in areas like the face, arms, and thighs can make you feel that you look oldernot healthier
What weight loss treatments does Hers offer
Onboarding flows also make a difference
OZMOSIs Data Intelligence Platforms: Driving Drug Development Strategies OZMOSI leverages advanced data collection, refinement, and indexing techniques to support clinical and commercial strategy development
Along with RAAS inhibitors, these therapies are increasingly regarded as foundational components of DKD management [19,133]